Tiajin Eye Hospital
Tianjin, Tianjin Municipality, China
Location status: Recruiting
NCT Number: NCT06211218
This study developed a deep learning algorithm based on anterior segment images and prospectively validated its ability to identify corneal diseases.The effectiveness and accuracy of this algorithm was evaluated by sensitivity, specificity, positive predictive value, negative predictive value, and area under curve.
Interested in participating?
Request InfoAll sexes
Observational
Tianjin, Tianjin Municipality, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1)Insufficient information for diagnosis.
An artificial intelligence algorithm was applied to diagnose cornea diseases from slit-lamp images.
Time frame: 1 week
We used the receiver operating characteristic (ROC) curve and area under curve to examine the ability of this artificial intelligence algorism recognition and classification of corneal diseases.
Time frame: 1 week
We used sensitivity and specificity to examine the ability of this artificial intelligence algorism recognition and classification of corneal diseases.
Contact information is provided by the study sponsor or research team.
Tianjin Eye Hospital
Other
Application of Deep Learning for Screening Multiple Corneal Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05204186
Bladder Cancer, Comorbidity
Amiens, Picardie, France
View Trial DetailsNCT06910956
Deep Learning, Early Cancer Detection
Boston, Massachusetts, United States
View Trial DetailsNCT06546592
Artificial Intelligence, Contouring
Dubbo, New South Wales, Australia
View Trial DetailsNCT07061821
Cardiac Magnetic Resonance Imaging, Cardiomegaly
Amiens, France
View Trial Details